Tropisetron-dexamethasone combination for carboplatin-induced emesis

被引：0
作者：
Pronzato, P
Ghio, E
Losardo, PL
Vaira, F
Vigani, A
机构：
来源：
ONCOLOGY REPORTS | 1996年 / 3卷 / 06期
关键词：
tropisetron; dexamethasone; carboplatin; emesis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sixty-six patients being given polychemotherapy schedules including carboplatin entered an antiemetic protocol with tropisetron and dexamethasone at the dose of 5 mg and 8 mg respectively. A complete response (no episodes of vomiting) and a major response (less than or equal to 2 episodes of vomiting) were observed in 55 and and 7 patients respectively. It is concluded that the tropisetron-dexamethasone combination is highly active in the control of emesis induced by conventional doses of carboplatin in combination.
引用
收藏
页码：1179 / 1181
页数：3
相关论文
共 10 条
  • [1] COMPARISON OF THE EMETOGENIC POTENTIAL BETWEEN CISPLATIN AND CARBOPLATIN IN COMBINATION WITH ALKYLATING-AGENTS
    DUBOIS, A
    VACH, W
    THOMSSEN, C
    KARCK, U
    MADJAR, H
    PROMPELER, H
    MEERPOHL, HG
    [J]. ACTA ONCOLOGICA, 1994, 33 (05) : 531 - 535
  • [2] REDUCTION OF CARBOPLATIN INDUCED EMESIS BY ONDANSETRON
    HARVEY, VJ
    EVANS, BD
    MITCHELL, PLR
    MAK, D
    NEAVE, LM
    LANGLEY, GB
    DICKSON, DSP
    [J]. BRITISH JOURNAL OF CANCER, 1991, 63 (06) : 942 - 944
  • [3] TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS IN THE 1990S - IMPACT OF THE 5-HT3 RECEPTOR ANTAGONISTS
    HESKETH, PJ
    [J]. SUPPORTIVE CARE IN CANCER, 1994, 2 (05) : 286 - 292
  • [4] Carboplatin and vinorelbine in advanced non-small-cell lung cancer
    Pronzato, P
    Ghio, E
    Losardo, PL
    Landucci, M
    Vaira, F
    Vigani, A
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (06) : 610 - 612
  • [5] Pronzato P, 1995, ANTICANCER RES, V15, P2261
  • [6] CARBOPLATIN, METHOTREXATE, AND VINBLASTINE IN OUTPATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    PRONZATO, P
    LANDUCCI, M
    VAIRA, F
    VIGANI, A
    BERTELLI, G
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (03): : 223 - 225
  • [7] PRONZATO P, 1995, ANTICANCER RES, V15, P517
  • [8] PRONZATO P, 1994, CHEMOTHERAPY, V40, P114
  • [9] ROILA F, 1993, J CLIN ONCOL, V12, P133
  • [10] 1995, NEW ENGL J MED, V332, P1
1